Sedor Pharmaceuticals

SEDOR PHARMACEUTICALS specializes in growth investments and turnaround opportunities within the pharmaceuticals and biologics industries. Led by John Sedor, a healthcare industry veteran with over 30 years of experience, SEDOR PHARMACEUTICALS identifies and acquires pharmaceutical and biologics companies and assets, leveraging its team’s deep expertise in development, operations, manufacturing, and commercialization to create value for investors. SEDOR PHARMACEUTICALS has licensed three clinical-stage compounds to establish its specialty pharmaceuticals platform. It recently filed for FDA approval for its leading injectable compound, CE-Fosphenytoin, used to treat status epilepticus, and is developing a second injectable compound, CE-Meloxicam, for the treatment of acute post-surgical pain.